Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1037792-44-1 Chemical Structure| 1037792-44-1

Structure of MBX-2982
CAS No.: 1037792-44-1

Chemical Structure| 1037792-44-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.

Synonyms: MBX-2982

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Bora, Prerona ; Zaman, Mashiat ; Oviedo, Samantha ; Kutseikin, Sergei ; Madrazo, Nicole ; Mathur, Prakhyat , et al.

Abstract: Pathogenic variants in the mitochondrial outer membrane GTPase MFN2 cause the peripheral neuropathy Charcot-Marie-Tooth Type 2A (CMT2A). These mutations disrupt MFN2-dependent regulation of diverse aspects of mitochondrial biology including organelle morphology, motility, mitochondrial-endoplasmic reticulum (ER) contacts (MERCs), and respiratory chain activity. However, no therapies currently exist to mitigate the mitochondrial dysfunction linked to genetic deficiencies in MFN2. Herein, we performed a drug repurposing screen to identify compounds that selectively activate the integrated stress response (ISR) – the predominant stress-responsive signaling pathway responsible for regulating mitochondrial morphology and function. This screen identified the compounds parogrelil and as potent and selective activators of the ISR through the OMA1-DELE1-HRI signaling axis. We show that treatment with these compounds promotes adaptive, ISR-dependent remodeling of mitochondrial morphology and protects mitochondria against genetic and chemical insults. Moreover, we show that pharmacologic ISR activation afforded by parogrelil restores mitochondrial tubular morphology, promotes mitochondrial motility, rescues MERCs, and enhances mitochondrial respiration in MFN2-deficient cells. These results demonstrate the potential for pharmacologic HRI activation as a viable strategy to mitigate mitochondrial dysfunction in CMT2A and other pathologies associated with MFN2 deficiency.

Purchased from AmBeed:

Alternative Products

Product Details of MBX-2982

CAS No. :1037792-44-1
Formula : C22H24N8OS
M.W : 448.54
SMILES Code : CCC1=CN=C(N2CCC(C3=NC(COC4=CC=C(N5N=NN=C5)C=C4)=CS3)CC2)N=C1
Synonyms :
MBX-2982
MDL No. :MFCD22628771
InChI Key :NFTMKHWBOINJGM-UHFFFAOYSA-N
Pubchem ID :25025505

Safety of MBX-2982

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of MBX-2982

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 1-10 μM 24 h MBX-2982 inhibited sorafenib-induced LC3B II protein expression, indicating suppression of autophagosome formation. J Exp Clin Cancer Res. 2018 Nov 29;37(1):295.
MDA-MB-231 cells 1-10 μM 24 h MBX-2982 inhibited gefitinib-induced LC3B II protein expression, indicating suppression of autophagosome formation. J Exp Clin Cancer Res. 2018 Nov 29;37(1):295.
MCF-7 cells 1-10 μM 24 h MBX-2982 inhibited gefitinib-induced LC3B II protein expression, indicating suppression of autophagosome formation. J Exp Clin Cancer Res. 2018 Nov 29;37(1):295.
HEK293 cells 10^−5M-10^−11M 30 min Measure cAMP accumulation to evaluate the activation of GPR119 by MBX-2982 Nat Commun. 2022 Nov 17;13(1):7033.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c-nu mice MCF-7 xenograft model Oral 10 mg/kg 5 times a week for 40 days Combination of MBX-2982 with gefitinib significantly inhibited the growth of MCF-7 xenograft tumors. J Exp Clin Cancer Res. 2018 Nov 29;37(1):295.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.29mL

4.46mL

2.23mL

References

 

Historical Records

Categories